Department of Medicine, University of Alberta, 2F1.24 Walter Mackenzie Health Sciences Centre, University of Alberta Hospital, Alberta, Canada.
Respir Med. 2010 Feb;104(2):260-6. doi: 10.1016/j.rmed.2009.09.013. Epub 2009 Oct 14.
Patients with COPD are at risk for osteoporosis-related vertebral compression fractures (VCF) which predispose to more fractures and worsening pulmonary function. Our objectives were to: 1 document VCF prevalence in COPD patients; and 2 determine the independent correlates of VCF.
From 2004-2006, we prospectively recruited consecutive consenting COPD patients presenting with acute exacerbation at three Canadian Emergency Departments (ED). We collected clinical and pulmonary function data. Primary outcome was radiologist documented VCF on chest radiograph. Multivariable logistic regression was used for all adjusted analyses.
Overall, 245 patients were studied; 37% were >or=75 years and 44% were women. Prevalence of VCF documented by chest radiograph was 22 of 245 (9%; 95%CI 6-13%). Almost half (10 of 22 [43%]) of VCF patients were not treated for osteoporosis and all 10 received oral steroids. Compared to patients without fractures, those with VCF were older (p=0.014), had COPD of longer duration (p=0.09) and greater severity (mean FEV(1) 0.9 vs 1.1L; p=0.05), and had lower body mass index [BMI] (median 26 vs 28; p=0.01). Across BMI quartiles (from heaviest [median 37] to lightest [median 21]) the prevalence of VCF progressively increased (2%, 8%, 10%, 21%; p<0.001). In analyses adjusted for age, sex, and COPD duration, the only independent correlate of VCF was BMI: VCF increased as BMI decreased from heaviest (OR=1) to lightest (OR=11.0) quartiles (p=0.025).
Almost one-tenth of COPD patients presenting with acute exacerbation have chest radiographs documenting VCF. About half of patients with VCF were not treated for osteoporosis, but all were started on oral steroids. Our findings suggest chest radiograph reports may represent an important case-finding tool for VCF, particularly in underweight patients with COPD.
COPD 患者存在骨质疏松性椎体压缩性骨折(VCF)风险,这会增加更多骨折和肺部功能恶化的风险。我们的目标是:1)记录 COPD 患者中 VCF 的患病率;2)确定 VCF 的独立相关因素。
2004 年至 2006 年,我们前瞻性地招募了在加拿大三个急诊科(ED)就诊的急性加重期连续同意的 COPD 患者。我们收集了临床和肺功能数据。主要结果是放射科医生在胸部 X 光片上记录的 VCF。所有调整分析均采用多变量逻辑回归。
共有 245 例患者接受了研究;37%的患者年龄≥75 岁,44%为女性。胸部 X 光片记录的 VCF 患病率为 22/245(9%;95%CI 6-13%)。几乎一半(10/22 [43%])的 VCF 患者未接受骨质疏松治疗,所有 10 例均接受了口服类固醇治疗。与无骨折患者相比,VCF 患者年龄更大(p=0.014),COPD 持续时间更长(p=0.09)且严重程度更高(平均 FEV1 为 0.9 升与 1.1 升;p=0.05),BMI 更低[中位数 26 与 28;p=0.01]。按 BMI 四分位数(最重[中位数 37]到最轻[中位数 21])计算,VCF 的患病率逐渐增加(2%、8%、10%、21%;p<0.001)。在调整年龄、性别和 COPD 持续时间的分析中,VCF 的唯一独立相关因素是 BMI:从最重(OR=1)到最轻(OR=11.0)四分位数,VCF 随着 BMI 的降低而增加(p=0.025)。
约十分之一的因急性加重就诊的 COPD 患者的胸部 X 光片有 VCF 记录。约一半的 VCF 患者未接受骨质疏松治疗,但所有患者均开始接受口服类固醇治疗。我们的研究结果表明,胸部 X 光片报告可能是 VCF 的重要病例发现工具,特别是在体重不足的 COPD 患者中。